Controversial New Alzheimer’s Drug Approved Despite Reservations


Follow via Flickr Link:

The Alzheimer's Association, Flickr

The U.S. Food and Drug Administration has approved the first new drug for Alzheimer’s disease in 20 years, but some doctors, including one at UAB, warned patients’ families not to expect much from the drug any time soon.

The drug, aducanumab, is expected to help slow the progression of the disease, but not to improve current memory impairments, according to a release from the University of Alabama at Birmingham. The university’s Division of Memory Disorders and the Alzheimer’s Disease Center have been involved in clinical trials of aducanumab for the past five years.

“The approval of the first disease-modifying therapy is a milestone for our field and a result of years of intense research. However, it must be understood that [aducanumab] is not expected to restore memory or reverse the symptoms of Alzheimer’s disease,” said Dr. David Geldmacher, professor of neurology at UAB and clinical core director of the center. “Instead, it is expected to slow the worsening of the disease. [Aducanumab] is likely the beginning of a new era in treating AD, but not the end of the story.”

Geldmacher said it would be some time before the drug is widely available, not all patients will be eligible to receive it, and many patients, especially with advanced disease, are not likely to see improvement from it.

The FDA approved the drug despite opposition from an independent advisory committee and some Alzheimer’s experts who said there was not enough evidence the drug helps patients, according to several news reports, including from the Associated Press.

The FDA did require the drugmaker, Biogen, to conduct another study to determine whether it benefits patients, and it could pull the drug from the market if its effectiveness is not proven.

Editor’s Note: UAB holds WBHM’s broadcast license, but our news and business departments operate independently.


Old Carraway complex to be demolished all at once under new deal with city

The former hospital site will be turned into a mixed-use development, Star at Uptown, which is to include residential, retail and dining spaces, as well as an amphitheater.

Attorney General says the execution review should happen quickly, that there is ‘no moratorium’

Last month, Gov. Kay Ivey asked Attorney General Steve Marshall not to seek additional execution dates for any other death row inmates until a review is complete.

Fire department says landfill blaze that spread smoke more than 20 miles away is ‘contained’

The Moody Fire Department determined that a landfill fire that has been burning largely underground has been contained.

UAB hires ex-NFL quarterback Trent Dilfer as head coach

The former NFL quarterback most recently spent four seasons as a high school football coach.

Alabama coal miners begin their 20th month on strike

The miners have survived more than 600 days on the picket line, thanks to widespread support and anger at their employer, Warrior Met Coal. Even now, neither side seems ready to budge.

Cameras, iPads part of plan to improve garbage collection

The City Council approved a software that they say will streamline garbage routes and and improve accountability.

More BirminghamWatch Coverage